[go: up one dir, main page]

UY32247A - Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones - Google Patents

Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones

Info

Publication number
UY32247A
UY32247A UY0001032247A UY32247A UY32247A UY 32247 A UY32247 A UY 32247A UY 0001032247 A UY0001032247 A UY 0001032247A UY 32247 A UY32247 A UY 32247A UY 32247 A UY32247 A UY 32247A
Authority
UY
Uruguay
Prior art keywords
compounds
aminociclohexilo
applications
new
same
Prior art date
Application number
UY0001032247A
Other languages
English (en)
Inventor
Cronin Mark
Geng Bolin
Reck Folkert
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY32247A publication Critical patent/UY32247A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a compuestos de Fórmula (I): y sales farmacéuticamente aceptables de los mismos, a su uso en el tratamiento de infecciones bacterianas y a sus métodos de preparación.
UY0001032247A 2008-11-14 2009-11-13 Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones UY32247A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11470608P 2008-11-14 2008-11-14
US16384809P 2009-03-26 2009-03-26

Publications (1)

Publication Number Publication Date
UY32247A true UY32247A (es) 2010-06-30

Family

ID=41463108

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032247A UY32247A (es) 2008-11-14 2009-11-13 Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones

Country Status (20)

Country Link
US (1) US20110288084A1 (es)
EP (1) EP2370444A1 (es)
JP (1) JP2012508789A (es)
KR (1) KR20110093797A (es)
CN (1) CN102216308A (es)
AR (1) AR074340A1 (es)
AU (1) AU2009315425A1 (es)
BR (1) BRPI0921148A2 (es)
CA (1) CA2742520A1 (es)
CO (1) CO6382113A2 (es)
CR (1) CR20110256A (es)
CU (1) CU20110108A7 (es)
EA (1) EA201100754A1 (es)
EC (1) ECSP11011053A (es)
IL (1) IL211941A0 (es)
MX (1) MX2011005106A (es)
TW (1) TW201022279A (es)
UY (1) UY32247A (es)
WO (1) WO2010055348A1 (es)
ZA (1) ZA201104395B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2840060A1 (en) * 2011-06-27 2013-01-03 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
AR096135A1 (es) * 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
TW201711999A (zh) 2015-09-03 2017-04-01 佛瑪治療公司 ﹝６，６﹞稠合雙環組蛋白脫乙醯基酶８（ｈｄａｃ８）抑制劑
SMT202000335T1 (it) * 2016-06-08 2020-07-08 Acraf Nuovi composti antibatterici
US10912780B2 (en) 2017-06-08 2021-02-09 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
NZ573032A (en) * 2006-05-26 2010-12-24 Taisho Pharmaceutical Co Ltd Antimicrobial heretocyclic compound and intermediates for its production
CL2007003693A1 (es) * 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.

Also Published As

Publication number Publication date
CR20110256A (es) 2011-07-04
US20110288084A1 (en) 2011-11-24
ECSP11011053A (es) 2011-06-30
CU20110108A7 (es) 2012-01-31
BRPI0921148A2 (pt) 2016-02-23
CO6382113A2 (es) 2012-02-15
JP2012508789A (ja) 2012-04-12
CN102216308A (zh) 2011-10-12
WO2010055348A1 (en) 2010-05-20
ZA201104395B (en) 2012-03-28
EP2370444A1 (en) 2011-10-05
TW201022279A (en) 2010-06-16
AR074340A1 (es) 2011-01-12
CA2742520A1 (en) 2010-05-20
EA201100754A1 (ru) 2012-01-30
IL211941A0 (en) 2011-06-30
AU2009315425A1 (en) 2010-05-20
MX2011005106A (es) 2011-05-30
KR20110093797A (ko) 2011-08-18

Similar Documents

Publication Publication Date Title
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
CO6290656A2 (es) Derivados heterociclicos de urea y metodos de uso de los mismos -211
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
UY30759A1 (es) Compuestos quimicos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
CR11861A (es) Compuestos organicos
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
CO6680667A2 (es) Derivados ester de ácido borónico cíclico y sus usos terapéuticos
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
CO6741203A2 (es) Derivados de biciclo[3,2,1]octilamida y sus usos
UA109010C2 (en) Morpholino pyrividines and their use in therapy
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY31141A1 (es) Compuestos de piperidina y sus usos
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
ECSP12012338A (es) Triazolopiridinas sustituidas
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
CO6351722A2 (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
UY32055A (es) Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181127